Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...

Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1 Strong PFS consistent across key subgroups Reaffirms selection of iSCIB1+ and ...

Eupraxia Pharmaceuticals , a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed ...

Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...

Bionano Genomics (BNGO) participated in the Association for Molecular Pathology Annual Meeting, held November 11-15, 2025 in Boston, MA. Key ...

Discover why Southern Company offers 12% upside and a 3.5% yield. Explore Q3 results, growth from data centers, and dividend ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presentation at the 2025 San Antonio Breast ...

AAEA invites media to attend their sessions at the ASSA 2026 Annual Meeting in Philadelphia, PA. On Sunday, January 4, 2026 at 8:00 am ? 10:00 am (EST) at the Marriott Philadelphia Downtown, four AAEA ...

Secret grand jury transcripts from Jeffrey Epstein's 2019 sex trafficking case can be made public, a judge ruled Wednesday, joining two other judges in granting the U.S. Justice Department's requests ...

Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23) and overall survival (HR=0.61; p=0.52)3/3 (100%) of ...

West Virginia residents are fighting state-backed plans for data center proliferation in their communities, citing ...

As part of Purdue’s Hovde Distinguished Lecture Series, Harvard professor Susan Murphy spoke at Purdue about improving AI ...